Comorbidity of COVID-19 - COPD: Characteristics and Evolution

According to studies, COPD is not a common comorbidity among people infected with SARS-CoV2. The frequency of COPD detection among comorbidities in patients with COVID-19 is less frequent than in the general population. However, COPD worsens the course of coronavirus infection, increasing the risk of adverse outcomes and death. Coronavirus infection in patients with COPD is more severe compared to other comorbidities and more often leads to hospitalization compared to other comorbidities. COPD, being a risk factor for severe COVID-19, increases the likelihood of rehospitalizations, transfers to intensive care units and increased mortality.